DHPA

  • Home
  • About Us
    • Leadership
      • Executive Committee
      • Board Members
    • DHPA Members
    • Contact Us
    • Join Us
  • Advocacy
    • Patient Access to Independent GI Care
      • Colorectal Cancer Screening
    • Diversity Equity and Inclusion
    • Modernizing the Stark Law
    • Saving the IOASE
    • Pathology Services Utilization
  • Resources
    • CRC Screening
    • Independent GI Careers
    • Research
    • Fact Sheets
    • Letters to Policymakers
    • Leadership Series
  • Newsroom
    • Press Releases
    • DHPA in the News
    • GI News Round Up
  • Take Action

August 9, 2021

MedPage Today: CMS Proposes to Rescind ‘Most Favored Nation’ Drug Pricing Rule

The Biden administration is planning to rescind a “Most Favored Nation” rule from the Trump administration that would have tested a model requiring that Medicare pay no more for certain drugs than the price paid by some other developed nations.

Nadeem Baig, MD, a gastroenterologist in Oakhurst, New Jersey, and a member of the board of directors of the Digestive Health Physicians Association, said at the time that the association was “distressed, to say the least, with the rushed process of this … interim final rule proposed last month, given the nature and lack of really appropriate input of stakeholders in this process, and skipping of many steps in the process of rule-making at the administrative level. We fear our patients would suffer.”

He noted that “by the government’s own estimates, one in five patients who get these life-altering drugs … would have lost that access,” according to a chart on page 184 of the interim final rule. “A key driver of their savings was the people who were not getting the drugs,” Baig said.

Patients who couldn’t get the drugs from an office-based gastroenterologist might have to scramble to find an alternate site, and “some patients would be driven to hospitals — which are full of COVID — to get these drugs, and usually hospitals charge a higher price to infuse these drugs,” he added. Read More at MedPage Today >>

Filed Under: DHPA in the News

Member Spotlight

Allied Digestive Health is a gastroenterology and hepatology practice with more than 50 locations throughout New Jersey and New York, specializing in colon cancer screening, and the treatment of Celiac Disease, GERD, and IBD.

Learn more at:
www.allieddigestivehealth.com

Become a Member

    Is your practice interested in promoting and preserving accessible, high quality and cost-efficient care in the independent GI medical setting? Contact us today about joining DHPA.

    Recent News

    • DHPA Supports the Protecting Patient Access to Cancer and Complex Therapies Act

    • DHPA Supports Guidelines that Recommend Colorectal Cancer Screening Starting at Age 45

    • Video: Establishing a Formal Mentorship Program in an Independent GI Practice

    • UnitedHealthcare’s Advance Notification Policy: Paperwork Over Patient Care

    • Statement on UnitedHealthcare’s Advance Notification Policy for Gastroenterology Services

    • Colorectal Cancer: Am I at Risk? Spanish Translation (Video)

    • The Value of Colonoscopy: The Gold Standard in Colorectal Cancer Screening (Video)

    • Colorectal Cancer: Am I at Risk? (Video)

    • The Value of Colonoscopy (Infographic)

    Digestive Health Physicians Association, Inc.
    10770 Columbia Pike, Suite 400
    Silver Spring, Maryland, 20901
    © 2020 DHPA

    Follow @DHPAnews
    Tweets by DHPAnews

    Copyright © 2023 · Executive Pro Theme on Genesis Framework · WordPress · Log in